Julie Lambert

Senior Director
20+ years of experience in healthcare technology, value creation, commercialization, and scaled operations as both a practice leader and a strategic advisor
Grows and transforms organizations of all sizes through market expansion, product innovation, operational excellence, customer experience optimization, and cost containment with sustainable performance
Tampa
@alvarezmarsal
LinkedIn
Copied!
Julie Lambert is a Senior Director with Alvarez & Marsal Healthcare Industry Group in Tampa.

Ms. Lambert brings extensive experience in healthcare technology, value creation, commercialization, and scaled operations as both a practice leader and a strategic advisor. As a leader in the healthcare industry, she has grown and transformed organizations of all sizes through market expansion, product innovation, operational excellence, customer experience optimization, and cost containment with sustainable performance.

Prior to joining A&M, Ms. Lambert was the President and General Manager of the Provider Business Unit at Inovalon, where she led strategic initiatives and business performance. Prior to that, she was Vice President of Specialty Pharmacy at Optum, contributing to innovation and growth within complex care delivery. While at Optum, she also served in various strategic and visionary advisory roles. Ms. Lambert spent over a decade at Prime Therapeutics, where she held multiple senior leadership roles, shaping enterprise strategy and driving transformational change.

Ms. Lambert earned a bachelor’s degree from the University of Wisconsin—La Crosse.

Latest insights The latest insights from Julie Lambert's team
Thought Leadership
Medical device supply chains are under increasing pressure as global disruption becomes a constant rather than an exception. From geopolitical volatility to material scarcity and regulatory complexity, the sector now operates in an environment where even minor shocks can have far-reaching consequences. This article explores the structural vulnerabilities shaping today’s MedTech supply networks and highlights why traditional approaches are no longer sufficient. It outlines how leading organisations are rethinking resilience not just as risk mitigation, but as a source of competitive advantage in an increasingly unpredictable world. Download the full article to uncover the strategies that are helping companies respond faster, protect patient outcomes, and maintain operational continuity.